News Impact
TEVA· last 90 days
TEVA PHARMACEUTICAL-SP ADR
Backward-looking only. These statistics describe how the price moved after past news. They are not a prediction. Sample sizes are small, market context differs every day, and past performance does not predict future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
1articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 1 events
- GlobalNewswire4/29/2026, 10:30:00 AMTeva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth StrategySentiment0.70Relevance100%+24h—+72h—+7d—
Not investment advice. See full disclaimer.